These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 3613889)

  • 41. Drug product selection legislation: a comparative analysis.
    Wetherbee H; Sharpe TR
    Am J Pharm Sci Support Public Health; 1978; 150(6):171-6. PubMed ID: 576098
    [No Abstract]   [Full Text] [Related]  

  • 42. Exploring generic drug use behavior: the role of prescribers and pharmacists in the opportunity for generic drug use and generic substitution.
    Mott DA; Cline RR
    Med Care; 2002 Aug; 40(8):662-74. PubMed ID: 12187180
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Plan defeated, but pharmacists still seek ability to prescribe.
    Carrell S
    Am Med News; 1982 May; 25(18):3, 9. PubMed ID: 10324199
    [No Abstract]   [Full Text] [Related]  

  • 44. Drug product selection: legal issues.
    Christensen TP; Kirking DM; Ascione FJ; Welage LS; Gaither CA
    J Am Pharm Assoc (Wash); 2001; 41(6):868-74. PubMed ID: 11765112
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Legal format and costs of prescriptions at the Central Hospital in Yaounde, Cameroon].
    Blatt A; Chambon R; Lemardeley P
    Med Trop (Mars); 1997; 57(1):37-40. PubMed ID: 9289607
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The pharmacist and generic drugs--a study of ampicillin.
    Smith MC
    J Am Pharm Assoc; 1972 Oct; 12(10):511-5. PubMed ID: 5069353
    [No Abstract]   [Full Text] [Related]  

  • 47. Evaluating pharmacists' views, knowledge, and perception regarding generic medicines in New Zealand.
    Babar ZU; Grover P; Stewart J; Hogg M; Short L; Seo HG; Rew A
    Res Social Adm Pharm; 2011 Sep; 7(3):294-305. PubMed ID: 21272551
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Web-based survey to assess the perceptions of managed care organization representatives on use of copay subsidy coupons for prescription drugs.
    Nemlekar P; Shepherd M; Lawson K; Rush S
    J Manag Care Pharm; 2013 Oct; 19(8):602-8. PubMed ID: 24074006
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Brand names, generic prescribing, and generic substitution.
    Pincus RC
    Med J Aust; 1983 Jul; 2(2):89-91. PubMed ID: 6679055
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Some observations on research methodologies used in drug product selection studies.
    Pathak DS; Simon LS
    Drug Intell Clin Pharm; 1980 Feb; 14(2):126-33. PubMed ID: 10246118
    [No Abstract]   [Full Text] [Related]  

  • 51. Informed consent and generic drug substitution.
    DeVeaugh-Geiss J
    Clin Ther; 1985; 7(5):544-8. PubMed ID: 4053144
    [No Abstract]   [Full Text] [Related]  

  • 52. Access to generic drugs in the 1950s: the politics of a social problem.
    Facchinetti NJ; Dickson WM
    Am J Public Health; 1982 May; 72(5):468-75. PubMed ID: 7065335
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Input to the discussion on proposed regulation of prescription pharmacies].
    Agência Nacional de Vigilância Sanitária - Anvisa
    Rev Saude Publica; 2005 Aug; 39(4):691-4. PubMed ID: 16113925
    [No Abstract]   [Full Text] [Related]  

  • 54. This prescription may be hazardous to your health: who is accountable to the patient?
    Walsh CB
    J Clin Psychopharmacol; 1993 Feb; 13(1):68-70. PubMed ID: 8486819
    [No Abstract]   [Full Text] [Related]  

  • 55. Letter: Antisubstitution vs. cooperative substitution.
    Jones ME; Helling DK; Widmer RB
    Am Fam Physician; 1976 Jul; 14(1):27. PubMed ID: 937160
    [No Abstract]   [Full Text] [Related]  

  • 56. States moving to allow generic substitution.
    Internist; 1979 May; 20(4):12-3. PubMed ID: 10242129
    [No Abstract]   [Full Text] [Related]  

  • 57. Brand versus generic prescribing: a perspective of the Indian cardiologists' viewpoint.
    Bansinath M; Sequeira RP; Shukla VK; Mathur VS
    Int J Clin Pharmacol Ther Toxicol; 1984 Jun; 22(6):279-83. PubMed ID: 6746151
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Get informed consent for risky drugs.
    Johnson LJ
    Med Econ; 2007 Nov; 84(21):20. PubMed ID: 18074929
    [No Abstract]   [Full Text] [Related]  

  • 59. More states adopt generic substitution laws.
    Goldsmith LS
    J Leg Med (N Y); 1977 Oct; 5(10):31-2. PubMed ID: 303272
    [No Abstract]   [Full Text] [Related]  

  • 60. Legal implications of diagnosis-related groups.
    Brooten KE
    Drug Intell Clin Pharm; 1986; 20(7-8):597-9. PubMed ID: 3091349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.